The Healthcare Sector currently makes up just over 9% of the ASX200 hence the 8% exposure MM is holding in our Flagship Growth Portfolio is slightly underweight, I’m glad we’ve avoided most of the sectors woes over the last 2-years but we all know in today’s market things are turning when least expected – 2-years ago everybody loved healthcare stocks today they hardly get a mention in market chat. MM believes the risk for bond yields is on the downside, if the market starts to embrace this view the Healthcare Sector could snap back into favour in the blink of an eye.
MM is considering increasing our exposure to ResMed (RMD) and CSL Ltd (CSL)
Add To Hit List
